268 related articles for article (PubMed ID: 19713852)
1. Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
Trojanowska M
Curr Opin Rheumatol; 2009 Nov; 21(6):623-9. PubMed ID: 19713852
[TBL] [Abstract][Full Text] [Related]
2. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.
Morris E; Chrobak I; Bujor A; Hant F; Mummery C; Ten Dijke P; Trojanowska M
J Cell Physiol; 2011 Dec; 226(12):3340-8. PubMed ID: 21344387
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
4. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.
Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M
Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation.
Haines P; Hant FN; Lafyatis R; Trojanowska M; Bujor AM
J Cell Mol Med; 2012 Sep; 16(9):2238-46. PubMed ID: 22277251
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
7. CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling network.
Nakerakanti SS; Bujor AM; Trojanowska M
PLoS One; 2011; 6(7):e21911. PubMed ID: 21760921
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway.
Bu S; Kapanadze B; Hsu T; Trojanowska M
J Biol Chem; 2008 Jul; 283(28):19593-602. PubMed ID: 18482992
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
[TBL] [Abstract][Full Text] [Related]
12. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
13. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
14. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
[TBL] [Abstract][Full Text] [Related]
15. Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels.
Bu S; Asano Y; Bujor A; Highland K; Hant F; Trojanowska M
Arthritis Rheum; 2010 Jul; 62(7):2117-26. PubMed ID: 20309867
[TBL] [Abstract][Full Text] [Related]
16. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.
Ihn H
J Dermatol Sci; 2008 Feb; 49(2):103-13. PubMed ID: 17628443
[TBL] [Abstract][Full Text] [Related]
17. Animal models of scleroderma: lessons from transgenic and knockout mice.
Derrett-Smith EC; Denton CP; Sonnylal S
Curr Opin Rheumatol; 2009 Nov; 21(6):630-5. PubMed ID: 19730378
[TBL] [Abstract][Full Text] [Related]
18. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]